Latest / Stock Movers / Micron Soars, Dell Falls, Bio-Techne Drops After Merck KGaA Secures $11.3 Billion Purchase
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio News, The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:13Speaker 1: harnessing the power of Bloomberg Data.
- 0:16Speaker 2: Let's take a look at some of the stocks on
- 0:18Speaker 2: the move today.
- 0:18Speaker 3: We can do that with Bloomberg's Avalon for now, Avlon.
- 0:21Speaker 3: What are you looking at today?
- 0:22Speaker 2: You have to start off with Micron. That's ticker MU
- 0:25Speaker 2: currently climbing about eleven percent, though earlier today it did
- 0:28Speaker 2: touch a record high, and that's up to a memory
- 0:30Speaker 2: chip maker. Gave a stronger than expected outlook for the
- 0:32Speaker 2: fiscal fourth quarter. While Street was really looking for Micron
- 0:36Speaker 2: to bring more assurance for the AI trade, and it
- 0:38Speaker 2: seems like it succeeded. It even got an upgrade from
- 0:40Speaker 2: Ersta Group, who said that the stock is still reasonably
- 0:43Speaker 2: valued despite its recent bull run.
- 0:46Speaker 3: All right, let's talk a little Dell, because sort of
- 0:49Speaker 3: below the radar here, but the stock's getting hit today
- 0:51Speaker 3: and it's one of the biggest losers right for the
- 0:53Speaker 3: S and P five hundred.
- 0:54Speaker 2: You're absolutely correct. That is ticker Dell currently sliding about
- 0:57Speaker 2: seven point four percent, making the company, as you said,
- 1:00Speaker 2: one of the worst performers and that's after GF Securities
- 1:03Speaker 2: downgraded the computer stock to hold from buy. At issue
- 1:07Speaker 2: is the more than two hundred percent rally since Dell
- 1:09Speaker 2: reported fourth quarter results in February. The analyst Jeff Poo
- 1:13Speaker 2: sees limited upside for Dell now given those really elevated expectations,
- 1:17Speaker 2: and he also says it's potentially just an uncompelling risk
- 1:20Speaker 2: reward right now.
- 1:23Speaker 1: Okay, what are you have?
- 1:23Speaker 3: Bio technee technique? Yes, okay, not at anything that we mentioned.
- 1:29Speaker 2: No, Yes, that is ticker tech and you're probably not
- 1:31Speaker 2: going to hear it that often anymore.
- 1:33Speaker 1: Now.
- 1:33Speaker 2: That has been bought by Merk KGaA that is the
- 1:37Speaker 2: German mark, not the US merk. It's currently surging about
- 1:40Speaker 2: nineteen percent most inter day since twenty twenty four, and
- 1:43Speaker 2: it was purchased for about eleven point three billion dollars.
- 1:46Speaker 2: This acquisition will help to expand Merks Life Sciences franchise.
- 1:50Speaker 2: And what is kind of important, though, is that the
- 1:52Speaker 2: Walls Street remains very split about this. William Blair views
- 1:56Speaker 2: the valuation as a bit disappointing, but says that regulatory
- 2:00Speaker 2: risk may have complicated other bids for this company. Still,
- 2:03Speaker 2: others are saying that the portfolios are very complimentary, so
- 2:06Speaker 2: it could be a good.
- 2:07Speaker 3: Fit the largest acquisition for MERK Germany in like a decade.
- 2:11Speaker 2: You're absolutely right, yes.
- 2:14Speaker 1: The Stockmovers Report from Bloomberg Radio. Check back with us
- 2:18Speaker 1: throughout the day for the latest roundup of companies making
- 2:21Speaker 1: news on Wall Street and for the latest market moving headlines.
- 2:25Speaker 1: Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg
- 2:29Speaker 1: dot com, and on Applecarplay and Android Auto with the
- 2:32Speaker 1: Bloomberg Business app.